Donation Program - Access to HIV Care®

Through the Access to HIV Care® Program, Abbott makes available Kaletra® and Norvir® at a loss to Abbott, and the HIV rapid test Determine® at no profit.

Abbott Access to HIV Care is the company's direct contribution to the fight against AIDS through broadened access to Abbott's HIV therapies and tests in 69 countries, including all of Africa. Through Abbott Access to HIV Care, the company offers Kaletra® and  Norvir® at a loss to Abbott. Abbott is the only pharmaceutical company to provide an HIV rapid test, Determine® HIV-1/2, at no profit, in addition to providing therapeutics as part of its access program. Abbott Access to HIV Care  is available to any organization or institution that provides products to patients as part of a sound and sustainable program of care.

The Program is one in a series of donations programs based on methods we helped develop. MCART provided all systems, data design, programming, front end work, and much conceptual planning.